MIMEDX GROUP, INC. cotiza a 4.69 USD y tiene una capitalización bursátil de $684M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent …
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.05 | $-0.05 | $0.14 |
| Estimado | — | $-0.03 | $-0.04 | $0.11 |
| Sorpresa | — | -66.7% | -25.0% | +27.3% |
| Métrica | MDXG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 82.6% | 57.0% | +25.5% |
| Operating Margin | 15.3% | -38.6% | +53.9% |
| Net Margin | 11.6% | -33.6% | +45.2% |
| FCF Margin | — | -13.9% | — |
| ROE | 18.9% | -40.4% | +59.3% |
| ROA | 14.2% | -32.0% | +46.2% |
| Current Ratio | 4.32 | 2.84 | +1.48 |
| Debt / Equity | 0.07 | 0.28 | -0.21 |